Allergan Pulls Textured Breast Implant Following FDA Request

Allergan followed a US Food and Drug Administration (FDA) request to recall its Biocell textured breast implants in response to an increase in breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) cases.